EP2448582
Kvínólín-8-súlfónamíð afleiður með virkni gegn krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.6.2010EP published:
19.4.2017EP application number:
10794668.3
EP translation filed:
16.6.2017Grant published:
15.7.2017EPO information:
European Patent Register
Max expiry date:
28.6.2030Expiry date:
28.6.2026Next due date:
30.6.2026
Title:
QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY
Timeline
Today
29.6.2010EP application
19.4.2017EP Publication
16.6.2017Translation submitted
15.7.2017Registration published
28.6.2026Expires
Owner
Name:
Agios Pharmaceuticals, Inc.Address:
88 Sidney Street, 02139, Cambridge, MA, US
Inventor
Name:
SAUNDERS, Jeffrey, O.Address:
Lincoln, MA, US
Name:
SALITURO, Francesco, G.Address:
Marlborough, MA, US
Name:
YAN, ShunqiAddress:
Irvine, CA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
292360 PDate:
5.1.2010Country:
US
Number:
221430 PDate:
29.6.2009Country:
US
Supplementary protection
SPC number:
SPC428
Classification
Categories:
A61K 31/497, A61K 31/5513, C07D 215/36, C07D 215/40, C07D 239/42, C07D 241/20, C07D 243/08, C07D 271/12, C07D 277/64, C07D 277/68, C07D 319/18, C07D 401/12, C07D 401/14, C07D 403/12, C07D 407/12, C07D 409/12, C07D 417/12, C07D 417/14, C07D 295/192, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 3.7.2017
Expires: 28.6.2018
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 19.6.2018
Expires: 28.6.2019
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 31.5.2019
Expires: 28.6.2020
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 2.6.2020
Expires: 28.6.2021
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 2.6.2021
Expires: 28.6.2022
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 1.6.2022
Expires: 28.6.2023
Payer: Patice ehf.
Number: 14
Paid: 11.6.2023
Expires: 28.6.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 31.5.2024
Expires: 28.6.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 18.6.2025
Expires: 28.6.2026
Payer: Árnason Faktor ehf.